Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0F7DS
|
|||
| Drug Name |
PMID26161698-Compound-18
|
|||
| Drug Type |
Small molecular drug
|
|||
| Company |
NOSCIRA, S.A
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C12H9ClN4O
|
|||
| Canonical SMILES |
C1=CC2=C(C=C1Cl)C(=C(N2)O)C3=NC(=NC=C3)N
|
|||
| InChI |
1S/C12H9ClN4O/c13-6-1-2-8-7(5-6)10(11(18)16-8)9-3-4-15-12(14)17-9/h1-5,16,18H,(H2,14,15,17)
|
|||
| InChIKey |
LHICLFBRLYHBGK-UHFFFAOYSA-N
|
|||
| PubChem Compound ID | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Cyclin-dependent kinase inhibitors for cancer therapy: a patent review (2009 - 2014).Expert Opin Ther Pat. 2015;25(9):953-70. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.